Protagonist Therapeutics (NASDAQ:PTGX) Coverage Initiated at Citigroup
Citigroup started coverage on shares of Protagonist Therapeutics (NASDAQ:PTGX – Free Report) in a research note issued to investors on Tuesday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $72.00 price target on the stock. PTGX has been the subject of a number of other reports. BTIG Research set a $73.00 price […]
Citigroup started coverage on shares of Protagonist Therapeutics (NASDAQ:PTGX – Free Report) in a research note issued to investors on Tuesday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $72.00 price target on the stock. PTGX has been the subject of a number of other reports. BTIG Research set a $73.00 price […]
